Experiment Treatment

AKA: Test Treatment, Experimental Treatment.
Context:
- It can (typcally) be an Active Treatment (except in an A/A Test).
- It can be given to a Treatment Group Member (in a Controlled Experiment).
- It can range from being Standard Treatment to being a Test Treatment.
- It can range from being a Therapeautic Treatment to being a Preventative Treatment.
- It can have a (measurable) Treatment Effect on an Experiment Subject.
- …
Example(s):
- a Standard Treatment, such as the application of penicillin to a wound with gram-positive bacteria.
- a Placebo Treatment, such as a sugar pill.
- an Experimental Treatment, such as a new antibiotic for a bacteria.
- a Randomized Controlled Experiment Treatment.
- …
Counter-Example(s):
See: Substance, Adverse Reaction, Control Group.

References

(Wikipedia, 2021) ⇒ https://en.wikipedia.org/wiki/Glossary_of_clinical_research#E Retrieved:2021-12-31.
- Experimental
  - In clinical trials, refers to a drug (including a new drug, dose, combination, or route of administration) or procedure that has undergone basic laboratory testing and received approval from the U.S. Food and Drug Administration (FDA) to be tested in human subjects. A drug or procedure may be approved by the FDA for use in one disease or condition, but be considered experimental in other diseases or conditions. Also called investigational. (NCI)

(Parienti & Kuss, 2007) ⇒ Jean-Jacques Parienti, and Oliver Kuss. (2007). “Cluster-Crossover Design: A method for limiting clusters level effect in community-intervention studies.” In: Contemporary Clinical Trials, 28(3). doi:10.1016/j.cct.2006.10.004
- QUOTE: The word “crossover” is mainly used to describe experiments in which all subjects receive both the test treatment|test and control treatments, usually delivered by the same team. In cluster-crossover studies, the statistical units are generally assigned to only one of the treatments